Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemogen is a biotechnology company specializing in the development and manufacture of high-quality diagnostic reagents for the detection of infectious diseases. Based in Maine, the company focuses on producing monoclonal antibodies and antigens specifically designed for environmental and clinical testing of waterborne and foodborne pathogens. Their core product line includes specialized reagents for identifying Cryptosporidium, Giardia, and E. coli O157:H7. Chemogen serves a global market, providing essential tools for diagnostic kit manufacturers and research laboratories involved in public health and food safety. The company is recognized for its expertise in hybridoma technology and large-scale antibody production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemogen.